Visual Snow; MS Drug Kickback Allegations

Visual Snow; MS Drug Kickback Allegations

Up next

Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases

Dr. Justin Abbatemarco talks with Dr. Paulus Rommer about the evolving understanding of Epstein-Barr virus (EBV) and its role in multiple sclerosis (MS), including recent research on EBV antibodies as diagnostic markers and potential therapeutic targets. Read the related article ...  Show more

Trends in Head CT Use in US Emergency Department Patients

Dr. Andy Southerland talks with Dr. Layne Dylla about the trends in head CT use in US emergency departments from 2007 to 2022, highlighting disparities, regional variations, and the potential role of AI in optimizing imaging decisions. Read the related article in Neurology®. Disc ...  Show more

Recommended Episodes

Old Drugs, New Disease
Chasing Life

As medical professionals search for new treatments to help Covid-19 patients, some researchers are taking a second look at drugs that have already been approved by the FDA. CNN Chief Medical Correspondent Dr. Sanjay Gupta talks to Dr. David Fajgenbaum about repurposing old drugs ...  Show more

The 2 Minute Medicine® Podcast- Episode 18
The 2 Minute Medicine® Podcast

We begin this episode by discussing our article of the week from the New England Journal of Medicine entitled “Hydrocortisone in severe community-acquired pneumonia.“. In the second half of our episode, we bring a medical eye to popular events. We begin with a discussion about ...

  Show more

Country Doctor on Medical Experiments with Dr. Charles Hoffe
RFK Jr Podcast

In this episode, Doctor Charles Hoffe and RFK Jr., discuss medical experimentation from World War II to today. Hoffe also reveals exciting new data on immunity evolution citing studies with former SARS patients.

Dr. Charles Hoffe was issued a gag order from the Canadian ...

  Show more

The future of psychedelic medicines and healthcare | Shoshana Clubhouse Conversation
TED Health

We’re in the midst of a psychedelic renaissance, where this once demonized class of drugs is now front and center receiving attention among entrepreneurs, investors, clinical trials and even patients. In this special conversation, TED Health’s Dr. Shoshana Ungerleider speaks with ...  Show more